Concepedia

Zhongyun Zhao

ZZ

Statistics

Publications

34

Citations

1.3K

H-Index

22

Active since

1999

Affiliations

Amgen (United States)(Current)

Eli Lilly (United States)

Thomson Reuters (United States)

Thomas Jefferson University

Antwerp University Hospital

Zhongyun Zhao is an author at Amgen (United States) specializing in medicine, oncology, and colorectal cancer.

ORCID

Publications per year

1999–2020

34

Publications

34

Equity in health care access to: assessing the urban health insurance reform in China

Gordon G. Liu, Zhongyun Zhao, Renhua Cai et al. · Social Science & Medicine · 2002 · 144 citations

, , +14

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)

J.M. Olivares, A. Rodríguez-Morales, Joris Diels et al. · European Psychiatry · 2009 · 142 citations

, , +17

Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice

Gregory P. Hess, Peter Feng Wang, David Quach et al. · Journal of Oncology Practice · 2010 · 87 citations · Full text

, , +17

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

Haya Ascher‐Svanum, Michael D. Stensland, Zhongyun Zhao et al. · BMC Psychiatry · 2005 · 74 citations · Full text

, , +17

Overall survival in patients with metastatic melanoma

Xue Song, Zhongyun Zhao, Beth Barber et al. · Current Medical Research and Opinion · 2015 · 69 citations

, , +17

1–5 of 34